Hirshfeld grants first USPTO director review after Arthrex
04-11-2021
Drew Hirshfeld: boosting quality and quantity at the USPTO
26-02-2018
Mark Van Scyoc / Shutterstock.com
The acting director of the US Patent and Trademark Office (USPTO) Andrew Hirshfeld has defended his right to review final Patent Trial and Appeal Board (PTAB) decisions under Arthrex.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
Andrew Hirshfeld, USPTO, IPR, PTAB, VirnetX, Apple, patents
